SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 155 filers reported holding SERES THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $253,829 | -87.6% | 106,651 | -70.6% | 0.00% | -96.8% |
| Q1 2023 | $2,054,377 | +980.2% | 362,324 | +966.9% | 0.03% | +675.0% |
| Q4 2022 | $190,187 | -44.6% | 33,962 | -66.0% | 0.00% | -55.6% |
| Q2 2022 | $343,000 | -77.4% | 99,950 | -54.1% | 0.01% | -79.1% |
| Q3 2021 | $1,515,000 | +1564.8% | 217,662 | +669.7% | 0.04% | +330.0% |
| Q2 2019 | $91,000 | – | 28,277 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 21,571,764 | $610,696,000 | 16.87% |
| RA Capital Management | 4,750,000 | $134,473,000 | 2.46% |
| ARK Investment Management | 12,293,033 | $348,016,000 | 2.06% |
| Opaleye Management Inc. | 335,312 | $9,493,000 | 1.86% |
| Sio Capital Management, LLC | 316,800 | $8,969,000 | 1.78% |
| Ikarian Capital, LLC | 762,400 | $21,585,000 | 1.56% |
| Nikko Asset Management Americas, Inc. | 5,531,670 | $152,176,000 | 1.35% |
| EAM Global Investors LLC | 121,629 | $3,443,000 | 1.26% |
| EAM Investors, LLC | 133,591 | $3,782,000 | 0.90% |
| GILDER GAGNON HOWE & CO LLC | 3,185,420 | $90,179,000 | 0.56% |